- Raised $1.44M in previous rounds.
- Key innovation: partially submerging infant in synthetic amniotic fluid that replicates the temperature and environment of the womb.
- 3 Years of R&D. Designed, sourced, procured and assembled Amniobed Golden Hour plus software.
- Patents issued in the US [2 patents] and China. Pending in Europe, Japan, India and Australia. US patent issued on artificial placenta.
Nearly 15M infants worldwide are born premature. Due to underdeveloped organs, the dramatic shift from amniotic fluid to air puts them at risk for hypothermia, dehydration, and infections which can lead to sepsis, organ injuries, and even death. To substantially improve preterm infants' chances of survival and reduce the time needed in intensive care, we designed AmnioBed, a patented, cost-efficient, fluid-filled solution that can mimics a mother's amniotic fluid environment.